The expression of SIRPα on macrophages in MDS patients was significantly reduced compared to that in normal controls (0.51% ± 0.09% versus 0.77% ± 0.06%, respectively; p < 0.05) (Figure 6). This evidence concerns the gene SIRPA and myelodysplastic syndrome.